Modotuximab (DS 1024) is an IgG1kappa-type chimeric antibody targeting human EGFR protein. Modotuximab binds non-overlapping epitopes on domain III of EGFR, a domain that is intact in EGFRvIII. Modotuximab has antitumor activity in vivo[1].
Molecular Weight:
(146.6 kDa)
Purity:
99.08
CAS Number:
[1310460-86-6]
Target:
EGFR
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted